Compile Data Set for Download or QSAR
Report error Found 375 with Last Name = 'hashimura' and Initial = 'k'
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  2.30nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 0.5 hrs by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50195695(CHEMBL3941037)
Affinity DataKd:  6.5nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 1 hr by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  0.740nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 2 hrs by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  0.740nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 2 hrs at room temperature by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50195695(CHEMBL3941037)
Affinity DataKd:  8.10nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 0.5 hrs by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  1.30nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 1 hr by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50195695(CHEMBL3941037)
Affinity DataKd:  6nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 2 hrs by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  0.490nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 4 hrs by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50195695(CHEMBL3941037)
Affinity DataKd:  10nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 4 hrs by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  0.340nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 2 hrs at 37 degC by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataKd:  23nMAssay Description:Binding affinity to recombinant human LPA1 expressed in CHO cell membranes measured after 2 hrs at 4 degC by scintillation counting methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataIC50: 0.160nMAssay Description:Antagonist activity at recombinant human LPA1 expressed in CHO cell membranes pretreated for 24 hrs prior to Fura-2-AM dye addition for 1 hr followed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetLysophosphatidic acid receptor 1(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50285779(CHEMBL4165205)
Affinity DataIC50: 0.190nMAssay Description:Antagonist activity at recombinant human LPA1 expressed in CHO cell membranes pretreated for 24 hrs prior to Fura-2-AM dye addition for 1 hr followed...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2017
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249335(US9463192, 15-96 | US9763943, 15-96 | US9993479, 1...)
Affinity DataIC50: 0.400nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2017
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249337(US9463192, 15-104 | US9763943, 15-104 | US9993479,...)
Affinity DataIC50: 0.5nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2017
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249345(US9463192, 21-65 | US9763943, 21-65 | US9993479, 2...)
Affinity DataIC50: 0.700nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-b1a CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:TrkA kinase-inhibiting activity in cell systems was measured using CHO-K1 cells expressing human TrkA and NFAT-bla (CellSenser TrkA-NFAT-bla CHO-K1 c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2020
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMT: 2°CAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/11/2017
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249336(US9463192, 15-98 | US9763943, 15-98 | US9993479, 1...)
Affinity DataIC50: 0.800nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249315(US9463192, 7 | US9763943, 7 | US9993479, 7 | US103...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249316(US9463192, 8-1 | US9763943, 8-1 | US9993479, 8-1 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249318(US9463192, 8-4 | US9763943, 8-4 | US9993479, 8-4 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249320(US9463192, 9-2 | US9763943, 9-2 | US9993479, 9-2 |...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249321(US9463192, 11 | US9763943, 11 | US9993479, 11 | US...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249323(US9463192, 14-5 | US9763943, 14-5 | US9993479, 14-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249324(US9463192, 14-6 | US9763943, 14-6 | US9993479, 14-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249325(US9463192, 15-4 | US9763943, 15-4 | US9993479, 15-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249334(US9463192, 15-87 | US9763943, 15-87 | US9993479, 1...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249339(US9463192, 21-1 | US9763943, 21-1 | US9993479, 21-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249340(US9463192, 21-2 | US9763943, 21-2 | US9993479, 21-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM340800(US9763943, 21-9)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249342(US9463192, 21-13 | US9763943, 21-13 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249343(US9463192, 21-37 | US9763943, 21-37 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249344(US9463192, 21-51 | US9763943, 21-51 | US9993479, 2...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249350(US9463192, 22-8 | US9763943, 22-8 | US9993479, 22-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM249356(US9463192, 22-9 | US9763943, 22-9 | US9993479, 22-...)
Affinity DataIC50: 1nMAssay Description:On the day before the assay, CellSenser TrkA-NFAT-bla CHO-K1 cells were suspended in an assay medium (Opti-MEM1 Reduced Serum Medium (Invitrogen) con...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/26/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 375 total ) | Next | Last >>
Jump to: